February 22, 2022 – The FDA has approved the first application for iPhone and Android devices that is capable of providing insulin doses to patients with diabetes.
Tandem Diabetes Care, an insulin delivery and diabetes technology company, said in a media release that its app will allow diabetic users to administer a dose of insulin through their smartphone. The app connects to Tandem’s t:slim X2 insulin pump, and is used for bolus insulin dosing, preventing glucose spikes after meals.
“This FDA clearance further validates our commitment to innovation and the diabetes community by providing one of the most requested feature enhancements,” John Sheridan, president and CEO of Tandem Diabetes Care said. “With the improvements in diabetes management provided by Tandem’s Control-IQ technology, giving a meal bolus is now the most common reason a person interacts with their pump, and the ability to do so using a smartphone app offers a convenient and discrete solution.
The FDA-cleared feature will be available to U.S. t:slim X2 insulin pump customers for free through a software update. Tandem plans to roll out the feature throughout the spring in a series of limited launch groups and through an expanded launch during the summer.